BiomX, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Basic Loss Per Share

Basic Loss Per Share

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

BASIC LOSS PER SHARE

NOTE 10

–

BASIC LOSS PER SHARE

The basic and diluted net loss per share and weighted average number of shares of Common Stock used in the calculation of basic and diluted net loss per share are as follows:

	Nine months ended September 30,
	2020		2019

Net loss		20,942		11,263
Interest accrued on preferred shares (pre-merger – BiomX Israel)		-		3,594
Net loss used in the calculation of basic net loss per share		20,942		14,857
Net loss per share		0.91		7.37
Weighted average number of shares of Common Stock		23,013,790		2,015,349

	Three months ended September 30,
	2020		2019

Net loss		8,835		4,260
Interest accrued on preferred shares (pre-merger – BiomX Israel)		-		1,212
Net loss used in the calculation of basic net loss per share		8,835		5,472
Net loss per share		0.38		2.69
Weighted average number of shares of Common Stock		23,150,253		2,035,625